A widely prescribed ADHD medication is being recalled nationwide after tests found it failed to dissolve properly in lab ...
Monthly olezarsen reduced triglycerides by 65% for people with severe hypertriglyceridemia, resulting in a greater than 85% ...
Deep, stable and durable reductions in kallikrein observed Among 32 patients who received a 50 mg dose of lonvo-z as of data ...
In a phase 1 trial, a gene-editing therapy that targets ANGPTL3 was associated with few serious adverse events and at higher ...
Dreyer’s Grand Ice Cream Inc. is recalling a limited number of its Häagen-Dazs Chocolate Dark Chocolate Mini Bars that may ...
These data were presented today during a late-breaking session at the American Heart Association (AHA) Scientific Sessions and published simultaneously in The New England Journal of Medicine (NEJM) in ...
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced positive results from the pivotal Phase 3 CORE and CORE2 studies ...
A widely prescribed ADHD medication is being recalled nationwide after tests found it failed to dissolve properly in lab ...
A pooled analysis of two phase 3 clinical trials shows that the first-in-class drug improves itching and itching-related ...
ATH434 improves daily function and reduces brain iron in patients with multiple system atrophy, a rare, fatal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback